GOLD|Important supply and demand areasCurrently, in the one-hour period, the $2060 area can be a good place for sell positions, of course, be careful not to enter the trade without confirmation.
In the first reaction to this area, it went up from the price of 2017$ to 2040$, it gave us a profit of about 230 pips. In the second reaction, collected all the liquidity at the bottom of the range and moved up 2% from there.And moved up about 450 pips.
Right now we see that it is bullish in reaction to the demand range.In smaller time frames, it is more likely that it will not react to the range ahead, so if it does not confirm, do not enter the trade.
There is a possibility that it will go up to the range of 2080. you can look for a sales position there.
This week, look for scalp positions in smaller time frames, even though gold is very bullish this week.
In the one-hour time frame, we have the supply and demand of these areas, when we reach these areas, we can have buy or sell positions.
Important_levels
Very High Chance of testing 50 Day EMA Nasdaq futures had a down day today which was perfect with the expectations that the markets were over bought since the recent lows. In the daily time frame there are very high chances that they will test the 50 day EMA level around 15,130 since that is the major support which is nearest to the price right now. Very high chances of having an inside day tomorrow.
KAVA Analysis and growth potential ( Fundamental + Technical )Hi friends.
Lets take a look at this incredible Altcoin and the coming upgrade KAVA 11 !
KAVA is a safe and scalable Layer 1 network and ecosystem built with the Cosmos SDK.
Kava Network announced on Twitter that Kava Liquid Staking would begin on September 8th with Kava 11.
It aims to help mainstream people see the value of DeFi by offering a trustworthy home for best-in-class DeFi services that can grow to meet global demand.
Now...
lets take a Technical view:
Like you can see in my chart we are in an important support zone.
and the price is moving in an ascending channel.we are in the bottom of this channel;'
also we are safe on the 50% retracement of the past impulsive wave and the price
Bounce from this level i think.
if the price Bounce from this level it can reach 2.30 or 2.40 targets;
however you should set your stoploss in below of this level and two recent bottoms (1.36 level)
the next target is 38.2% of recent correction that landed around 200MA (2.80 level)
Hope you have good trades.
dont forget to control your risk.
$INDO Next Target PTs 18-30 and higherIndonesia Energy Corporation Limited operates as an oil and gas exploration and production company in Indonesia. It holds interests in the Kruh Block, a producing block covering an area of 258 square kilometers with net crude oil proved reserves of 1.52 million barrels located to the northwest of Pendopo, Pali, South Sumatra; and the Citarum Block, an exploration block covering an area of 3,924.67 square kilometers located onshore in West Java. The company was incorporated in 2018 and is headquartered in Jakarta, Indonesia. Indonesia Energy Corporation Limited is a subsidiary of Maderic Holding Limited.
$PETZ Next Target PTs 5-8 and higherTDH Holdings, Inc., together with its subsidiaries, develops, manufactures, and sells pet food products for pet owners in the People's Republic of China, Asia, Europe, and North America. It offers approximately 200 products, which include 4 product lines consisting of pet chews, dried pet snacks, wet canned pet food, and dental health snacks, as well as non-food items, such as dog leashes, pet toys, etc. The company sells its products under the Pet Cuisine, Hum & Cheer, and various other brand names. It offers its products to retailers and wholesalers, as well as through e-commerce platform. The company was founded in 2002 and is based in Qingdao, the People's Republic of China.
IMPORTANT NEXT COMING WEEKS - GZ1! - GAZPROM - WEEKLYGZ1! - GAZPROM - WEEKLY
Gazprom price have at the end of last year reached its top price levels from 2007 - 2008.
It seems that it probably goes down every times it reaches that point.
After a long horizontally ranging price. we have seem a move up in the price.
From February the price started to decrease but it stays up in the channel, recovering to it up trending price.
It been few weeks that we have notices a slow down and the price is now evolving under the probable new up trending trend pictured by the green line.
Coming week are pictured with a light red zone and an eye for you be able to observe while the price is evolving in the square.
Probabilities are the bottom of the channel in the short direction and above the green line to keep going up in the long direction.
FLUX project , a potential blockchain for futureHi all.
we have a long term analysis on FLUX in 1W chart.
as you see on my chart after compelete a full cycle of 1-2-3-4-5 and ABC waves
we have a potential to start a new impulsive wave.
of course this correction may be extend and lasts more.
i draw cycle lines (Blue vertical lines) and we see ABC correction lasts 2 cycles and now is in the end of cycle.
this means correction last 2 time more than impulsive wave and have a potential to reverse.
for the end of ABC correction we have a lot of reason and levels like:
1-we are in the range of recent impulsive wave 4
2-we see a strong support level there(i show it with a purple rectangle)
3-recent impulsive wave fibonachi retracement 50% level
4-wave A projection 200% fibo level
5-POC(point of control) is here.
so i think this altcoin have a lot of technical potential for amazing growth.
if we see this blockchain website,we found it good protocol with amazing roadmap.
runonflux.io
what we need is a liitle good news for inflation this week...
have good investing and dont forget to manage your risks.
!!!NOTE!!!
MY POSTS ARE NOT TRADING AND INVESTING ADVISE
SO TRADE ON YOUR OWN STRATEGY AND CONSIDER MARKET RISKS.
Bitcoin Onchain Volume and Trading volumeHello guys.today i want to explain how we can find important Resistance and Support levels in BTC
according to onchain transaction volumes and trading or off chain volumes.
when we talk about onchain volume means Vol of transactions recorded in blockchain.
and when we talk about Trading Vol or offchain Vol means transactions recorded in exchanges.
Comparing on-chain and off-chain transaction volume can help us verify that data on exchange trading volume is accurate.
Off-chain volume should behave in the same way as on-chain volume.
We need this metrics in Tradingview
1)BCHAIN/TRVOU - QUANDL ----> this metric shows trading volume in Exchanges daily(Blue chart)
2)BTC_TXVOLUME - INTOTHEBLOCK ----> this metric shows BTC onchain volume daily(Purple chart)
and the price chart attached between this two metrics in my charts above.(Orange chart)
so when the trading volume and onchain volume grows together , we can see bounce or fall in price.
i show the trading volume and onchain volume Highs with colorful vertical lines
and illustrate important support and resistance levels this highs show on my chart with colorful horizontal lines.
according to this method , below we have important levels in BTC price that volume grows strong so
a lot of coins move from hand to hand.
this levels are : 19700 - 20500 - 32500 - 37200 - 43200 - 48000 - 56000 - 61500
Hope you like my opinion and if you have notices about it please share me in comments.
thank you all.
CME gap 9 may 2022Hello friends.
are you okay?
thanks god...
because crypto market open green in monday we can still see it bullish for mid time.
and we have some factors that show this opinion and strenghen our analyze
lets look at them :
1-we can see two important levels of fibo retracement around CME gap.
these levels are 38.2% and 61.8%.
so we have an overlap area here.
2-we have a gap in CME from 9 may 2022.
because of weak momentum market couldnt fill it until now.
but if we breakout this pattern that i illustrate in chart we can fill it!
3-we have an old trendline that can be act as an resistance level there.
4-moving average 55 is here just around levels that cme gap occured.
5-and in the end i see increase in volumes in lower levels of this pattern
and it could be showing that we have good supports in this levels.
.
.
.
dont forget to manage your capital and risk.
.
.
.
if you take a trade you must set a good stoploss.
(NOTE!!! this article is my own opinion and its not a trade advice.
please tarde on your own opinion and use others opinion to improve your
analyze.)
.
.
.
so i will do that.please support me and i wish use your experience
and you can help me to improve my abilities.
thank you all.have good days.
$POLA Next Target PTs 7-13-30 and higherPolar Power, Inc. designs, manufactures, and sells direct current (DC), power generators, renewable energy, and cooling systems in the United States and internationally. It offers DC base power systems, DC hybrid power systems, and DC solar hybrid power systems. The company serves customers in the telecommunications, military, commercial, industrial, and marine markets. It sells its products through direct sales force, and a network of independent service providers and dealers. The company was formerly known as Polar Products, Inc. and changed its name to Polar Power, Inc. in October 1991. Polar Power, Inc. was incorporated in 1979 and is based in Gardena, California.
Ontology (ONT) Buy ZoneOntology (ONT) Buy Zone
--------------------
BIAS
Mid-Term : Neutral
Long-Term : Neutral
Risk : High
With Ontology on 4 hours timeframe retesting once again our impotant mid-term level around $0.43 zone and showing short-term bounce.
--------------------
$ONT/USDT LONG SETUP
Leverage : x3 - x5
Entry Price : 0.415 - 0.4315
TP 1 : 0.4475
TP 2 : 0.465
TP 3 : 0.493
TP 4 : 0.511
TP 5 : 0.535
TP 6 : 0.5575
TP 7 : 0.57
TP 8 : 0.5925
Stop Loss : 0.399
*Maximum 3% of Portfolio.
*Unload 12.5% at each TP. Whenever TP 2 hits, Move stop loss to entry.
--------------------
$ENSVEnservco Corporation, through its subsidiaries, provides well enhancement and fluid management services to the onshore oil and natural gas industry in the United States. It offers frac water heating, hot oiling, pressure testing, acidizing, bacteria and scale treatment, freshwater and saltwater hauling, fluid disposal, frac tank rental, well site construction, and other general oil field services. The company owns and operates a fleet of approximately 338 specialized trucks, trailers, frac tanks, and other well-site related equipment. It operates in the eastern United States region comprising the southern region of the Marcellus Shale formation and the Utica Shale formation in eastern Ohio; Rocky Mountain region consisting of western Colorado and southern Wyoming, central Wyoming, western North Dakota, and eastern Montana; and the Central United States region, including Eagle Ford Shale and Permian Basin in Texas. Enservco Corporation was incorporated in 1980 and is headquartered in Longmont, Colorado.
$GBRNew Concept Energy, Inc. engages in real estate rental business. It owns approximately 190 acres of land located in Parkersburg West Virginia. The company was formerly known as CabelTel International Corporation and changed its name to New Concept Energy, Inc. in May 2008. The company was founded in 1978 and is based in Dallas, Texas. New Concept Energy, Inc. is a subsidiary of Arcadian Energy, Inc.
$DAVE entry PT 10 Target PT 15 and higherDave, Inc. engages in the development of a financial management mobile application to prevent bank overdrafts. It operates Dave, a financial platform that helps customers with banking, financial insights, overdraft protection, building credit, and finding side gigs. The company also provides Dave Banking, a spending account and debit card. Dave, Inc. was founded in 2017 and is based in Los Angeles, California.
$PROG Next Target PT 2.25 and higherProgenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. It offers Innatal, a noninvasive prenatal screening test offered to women early in pregnancy to screen for chromosome abnormalities, such as down syndrome, trisomy 18, trisomy 13, and sex chromosome disorders through the analysis of cell-free DNA; Preparent that screens for carrier status of hereditary diseases prior to or early in pregnancy; and Riscover, a hereditary cancer screen that analyzes 31 genes associated with inherited risk of 12 types of cancers, including the BRCA1/2 genes for hereditary breast, ovarian, colorectal, endometrial, pancreatic, and other cancer syndromes, as well as for the five genes associated with Lynch syndrome. The company also provides Resura, a noninvasive prenatal test for families at risk for rare single gene disorders; and Preecludia, a preeclampsia rule-out test. In addition, it offers anatomic and molecular pathology tests, and COVID-19 PCR testing services, as well as test products that includes chromosomal microarray for pregnancy loss, which evaluates the genetic cause of miscarriage; maternal serum screening for chromosomal disorders; and preimplantation genetic testing for use with artificial reproductive technologies. Further, the company develops therapeutic solutions for gastrointestinal-related disorders, such as PGN-001, PGN-300, PGN-600, and PGN-OB2. It also owns and operates laboratory. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November 2013. The company was founded in 2010 and is headquartered in San Diego, California.
$RELI – SI 183%Reliance Global Group, Inc. engages in the acquisition and management of wholesale and retail insurance agencies in the United States. It provides healthcare and Medicare, personal and commercial, trucking and transportation, and employee benefits insurance products. The company was formerly known as Ethos Media Network, Inc. and changed its name to Reliance Global Group, Inc. in October 2018. Reliance Global Group, Inc. was incorporated in 2013 and is headquartered in Lakewood, New Jersey.
$ARDX Support and ResistanceArdelyx shares are trading higher after Ladenburg Thalmann upgraded the stock from Neutral to Buy and announced a $6 price target. Also, Citigroup maintained a Buy rating and raised its price target from $7 to $13.
Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase 3 clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program that is in Phase 2 clinical trial for the treatment of patients with hyperkalemia; and RDX020, a small molecule program for the treatment of metabolic acidosis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Fremont, California.
$SCYX entry PT 6-6.71 Long term PT 18 and higherScynexis to Initiate a Phase 3 Study of Oral Ibrexafungerp as a Step-Down Treatment for Invasive Candidiasis Following Meeting With FDA
SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company develops ibrexafungerp, which has completed Phase II clinical trials for the treatment of vulvovaginal candidiasis. It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
$CPIXCumberland Pharmaceuticals shares are trading higher after the company announced the FDA approved expanded labeling for Caldolor to now include use in pre-operative administration.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ injection, for the treatment of certain serious bacterial infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. The company markets and sells its products through sales representatives and district managers. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
$MMATMeta Materials Inc., a smart materials and photonics company, invents, designs, develops, and manufactures various functional materials and nanocomposites. The company's products include metaAIR, a laser glare protection eyewear; NANOWEB, a revolutionary transparent conductive film; and holoOPTIX, a holographic optical component. Its products include aerospace and defense, automotive, consumer electronics, energy, and medical applications. The company is headquartered in Dartmouth, Canada.